KFAS
INDV icon

Keating Financial Advisory Services’s Indivior Pharmaceuticals INDV Stock Holding History

Keating Financial Advisory Services’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6K Buy
526
+461
+709% +$16.7K ﹤0.01% 961
2026
Q1 		$1.98K Buy
65
+34
+110% +$1.12K ﹤0.01% 1850
2025
Q4 		$1.11K Buy
+31
New +$947 ﹤0.01% 1768

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Keating Financial Advisory Services's INDV Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Indivior Pharmaceuticals (INDV) stake by 709% in Q2 2026, buying an estimated $16.7K and bringing the position to 526 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #961.

Keating Financial Advisory Services first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Keating Financial Advisory Services held 526 shares of Indivior Pharmaceuticals worth $21.6K as of Q2 2026.
  • Keating Financial Advisory Services bought 461 Indivior Pharmaceuticals shares in Q2 2026, an estimated $16.7K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #961 holding.
  • Keating Financial Advisory Services first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.